AI stethoscope could spot hidden heart disease early

NCT ID NCT07147725

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study will test whether an artificial intelligence (AI) system can detect pulmonary hypertension and other heart diseases using a smart stethoscope. Researchers will collect heart sound and ECG recordings from 1,000 adults already scheduled for routine echocardiography. The goal is to see if the AI can accurately identify heart problems compared to standard ultrasound imaging. If it works, this could lead to a simple, non-invasive screening tool for early detection.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AI-powered smart stethoscope (device)
What this could lead to
If successful, this could lead to a non-invasive, AI-driven tool for early detection of pulmonary hypertension and other heart conditions, potentially improving diagnosis and outcomes.
What could go wrong
This is an early validation study, not a treatment trial. The AI algorithms may not perform as well in real-world settings as hoped, and the results may not apply to all patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES (CVD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Imperial College Healthcare NHS Trust

    London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.